22nd Century Operating Margin 2011-2024 | XXII

Current and historical operating margin for 22nd Century (XXII) over the last 10 years. The current operating profit margin for 22nd Century as of September 30, 2024 is -120.20%.
22nd Century Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $0.03B $-0.02B -85.19%
2024-06-30 $0.03B $-0.03B -96.55%
2024-03-31 $0.03B $-0.04B -131.03%
2023-12-31 $0.03B $-0.04B -137.50%
2023-09-30 $0.02B $-0.03B -130.43%
2023-06-30 $0.03B $-0.04B -108.82%
2023-03-31 $0.04B $-0.04B -87.50%
2022-12-31 $0.04B $-0.03B -82.50%
2022-09-30 $0.05B $-0.04B -84.00%
2022-06-30 $0.04B $-0.04B -89.74%
2022-03-31 $0.03B $-0.03B -96.97%
2021-12-31 $0.03B $-0.03B -93.55%
2021-09-30 $0.03B $-0.03B -86.67%
2021-06-30 $0.03B $-0.02B -75.86%
2021-03-31 $0.03B $-0.02B -74.07%
2020-12-31 $0.03B $-0.02B -70.37%
2020-09-30 $0.03B $-0.02B -70.37%
2020-06-30 $0.03B $-0.02B -88.46%
2020-03-31 $0.03B $-0.02B -88.46%
2019-12-31 $0.03B $-0.02B -96.00%
2019-09-30 $0.03B $-0.02B -96.00%
2019-06-30 $0.03B $-0.02B -88.00%
2019-03-31 $0.03B $-0.02B -92.31%
2018-12-31 $0.03B $-0.02B -92.31%
2018-09-30 $0.03B $-0.02B -88.00%
2018-06-30 $0.02B $-0.02B -79.17%
2018-03-31 $0.02B $-0.02B -71.43%
2017-12-31 $0.02B $-0.01B -76.47%
2017-09-30 $0.01B $-0.01B -85.71%
2017-06-30 $0.01B $-0.01B -100.00%
2017-03-31 $0.01B $-0.01B -109.09%
2016-12-31 $0.01B $-0.01B -100.00%
2016-09-30 $0.01B $-0.01B -100.00%
2016-06-30 $0.01B $-0.01B -100.00%
2016-03-31 $0.01B $-0.01B -100.00%
2015-12-31 $0.01B $-0.01B -133.33%
2015-09-30 $0.01B $-0.02B -250.00%
2015-06-30 $0.00B $-0.02B -500.00%
2015-03-31 $0.00B $-0.02B -1500.00%
2014-12-31 $0.00B $-0.01B inf%
2014-09-30 $0.01B 0 0.00%
2014-06-30 $0.01B $0.00B 28.57%
2013-09-30 $0.00B $-0.01B inf%
2012-09-30 $0.00B $-0.00B inf%
2011-12-31 $0.00B $-0.00B -400.00%
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.002B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $189.954B 19.21
Altria (MO) United States $89.808B 10.56
British American Tobacco (BTI) United Kingdom $76.672B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $27.067B 0.00
Universal (UVV) United States $1.345B 10.53
Turning Point Brands (TPB) United States $1.039B 19.97